Does optimal lesion preparation reduce the amount of acute recoil of the absorbe BVS? Insights from a real-world population

Catheterization and Cardiovascular Interventions

Volumn 86, Issue 6, 2015, Pages 984-991

  Danzi, Gian Battista ^a   Sesana, Marco ^b   Arieti, Mario ^b   Villa, Giuliano ^b   Rutigliano, Sergio ^b   Aprile, Alessandro ^b   Nicolino, Annamaria ^a   Moshiri, Shahram ^a   Valenti, Renato ^c  

^a SANTA CORONA HOSPITAL   (Italy)

^b Ospedale di Desenzano del Garda   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

bioresorbable scaffold; coronary artery disease; recoil; stent

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE STENT RECOIL; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BIOABSORBABLE VASCULAR SCAFFOLD; BIORESORBABLE SCAFFOLD; CONTROLLED STUDY; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT COMPLICATION; VIDEODENSITOMETRY; AGED; BIODEGRADABLE IMPLANT; COHORT ANALYSIS; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FOLLOW UP; ITALY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROCEDURES; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RADIOGRAPHY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EVEROLIMUS; METAL;

ABSORBABLE IMPLANTS; ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; EVEROLIMUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; METALS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84947044354     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.26148     Document Type: Article

References (20)

1. Di Mario C, Caiazzo G., Biodegradable stents: The golden future of angioplasty? Lancet 2015; 385: 10-12.
2. Ormiston JA, Serruys PW., Bioabsorbable coronary stents. Circ Cardiovasc Interv 2009; 2: 255-260.
3. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, Mc Greevy R, Veldholf S., A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): A prospective open-label trial. Lancet 2008; 371: 899-907.
4. Tanimoto S, Serruys PW, Thuesen L, Dudek D, de Bruyne B, Chevalier B, Ormiston JA., Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv 2007; 70: 515-523.
5. Serruys PW, Chevalier B, Dudek D, Cequier A, Carriè D, Iniguez A, Dominici M, van der Schaaf R, Haude M, Wasungu L, Veldholf S, Peng L, Staehr P, Grundeken M, Ishibashi Y, Garcia-Garcia HM, Onuma Y., A bioresorbable everolimus-eluting scaffold versus metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An inteerim 1-year analysis of clinical and procedural secondary outcomes from randomized controlled trial. Lancet 2015; 385: 43-54.
6. Zhang YJ, Bourantas CV, Muramatsu T, Iqbal J, Farooq V, Diletti R, Campos CA, Onuma Y, Garcia-Garcia HM, Serruys PW., Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: An exploratory observational study prior to a randomised trial. EuroIntervention 2014; 10: 672-680.
7. Mattesini A, Secco GG, Dall'Ara G, Ghione M, Rama-Merchan JC, Lupi A, Viceconte N, Lindsay AC, De Silva R, Foin N, Naganuma T, Valente S, Colombo A, Di Mario C., ABSORB biodegradable stents versus second-generation metal stents: A comparison study of 100 complex lesions treated under OCT guidance. JACC Cardiovasc Interv 2014; 7: 741-750.
8. Onuma Y, Serruys PW, Gomez J, De Bruyne B, Dudek D, Thuesen L, Smits P, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Garcia-Garcia H, Ormiston JA., Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (Revision 1.0 and 1.1) and the metallic everolimus-eluting stent. Catheter Cardiovasc Interv 2011; 78: 3-12.
9. Attizzani GF, Ohno Y, Capodanno D, Francaviglia B, Grasso C, Sgroi C, Wang W, Fujino Y, Ganocy SJ, Longo G, Tamburino CI,D, Salvo M, La Manna A, Capranzano P, Tamburino C., New insights on acute expansion and longitudinal elongation of bioresorbable vascular scaffolds in vivo and at bench test: A note of caution on reliance to compliance charts and nominal length. Catheter Cardiovasc Interv 2015; 85: E99-E107
10. Tsuchida K, Piek J, Neumann FJ, van der Giessen WJ, Wiemer M, Zeiher A, Grube E, Haase J, Thuesen L, Hamm C, Veldhof S, Dorange C, Serruys PW., One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial). EuroInterv 2005; 1: 266-272.
11. Tommasini G, Rubartelli P, Piaggio M., A deterministic approach to automated stenosis quantification. Catheter Cardiovasc Interv 1999; 48: 435-445.
12. Johnson MR, Skorton DJ, Ericksen EE, Fleagle SR, Wilson RF, Hiratzka LF, White CW, Marcus ML, Collins SM., Videodensitometric analysis of coronary stenoses: In vivo geometric and physiologic validation in humans. Invest Radiol 1988; 23: 891-898.
13. Strauss BH, Juilliere Y, Rensing BJ, Reiber JH, Serruys PW., Edge detection versus densitometry for assessing coronary stenting quantitatively. Am J Cardiol 1991; 67: 448-490.
14. Danzi GB, Fiocca L, Capuano C, Predolini S, Quaini E., Acute stent recoil: In vivo evaluation of different stent designs. Catheter Cardiovasc Interv 2001; 52: 147-153.
15. Foley DP, Serruys PW., Provisional stenting-stent-like balloon angioplasty: Evidence to define the continuing role of balloon angioplasty for percutaneous coronary revascularization. Semin Interv Cardiol 1996; 1: 269-273.
16. Schiele F, Meneveau N, Gilard M, Boschat J, Commeau P, Pin Ming L, Sewpke P, Seronde MF, Mercier M, Gupta S, Bassand JP., Intravascular ultrasound-guided balloon angioplasty compared with stent: Immediate and 6-month results of the multicenter, randomized balloon equivalent to stent study (BEST). Circulation 2003; 107: 545-551.
17. Huber MS, Mooney JF, Madison J, Mooney MR., Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 1991; 68: 467-471.
18. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, Ditrano CJ, Leon MB., Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation 1995; 91: 1959-1965.
19. Oberhauser JP, Hossainy S, Rapoza RJ., Design principles and performance of bioresorbable polymeric vascular scaffold. Eurointervention 2009; 5: F15-F22.
20. Aziz S, Morris JL, Perry RA, Stables RH., Stent expansion: A combination of delivery balloon underexpansion and acute stent recoil reduces predicted stent diameter irrespective of reference vessel size. Heart 2007; 93: 1562-1566.